Factors Associated with Adoption of Immune Checkpoint Inhibitor Treatment for Advanced Melanoma: A SEER-Medicare Cohort Study

• मुख्य लेखकों: Cassandra Mohr (लेखक), Kaiping Liao (लेखक), Candice L. Hinkston (लेखक), Mackenzie R. Wehner (लेखक), Meng Li (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2024-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

We aimed to explore the differences in immune checkpoint inhibitor (ICI) immunotherapy utilization for advanced melanoma by examining patient and neighborhood characteristics. We performed a retrospective cohort study using a deidentified, random sample of SEER-Medicare beneficiaries aged ≥65 years...